Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Related Citations for PubMed (Select 24195609)

1.

One, two and three-dimensional ultrasound measurements of carotid atherosclerosis before and after cardiac rehabilitation: preliminary results of a randomized controlled trial.

Lindenmaier TJ, Buchanan DN, Pike D, Hartley T, Reid RD, Spence JD, Chan R, Sharma M, Prior PL, Suskin N, Parraga G.

Cardiovasc Ultrasound. 2013 Nov 6;11:39. doi: 10.1186/1476-7120-11-39.

2.

Comparison of B-mode ultrasound, 3-dimensional ultrasound, and magnetic resonance imaging measurements of carotid atherosclerosis.

Egger M, Krasinski A, Rutt BK, Fenster A, Parraga G.

J Ultrasound Med. 2008 Sep;27(9):1321-34.

3.

Longitudinal ultrasound evaluation of carotid atherosclerosis in one, two and three dimensions.

Mallett C, House AA, Spence JD, Fenster A, Parraga G.

Ultrasound Med Biol. 2009 Mar;35(3):367-75. doi: 10.1016/j.ultrasmedbio.2008.09.008. Epub 2008 Nov 8.

PMID:
18996639
4.

Progression of carotid plaque volume predicts cardiovascular events.

Wannarong T, Parraga G, Buchanan D, Fenster A, House AA, Hackam DG, Spence JD.

Stroke. 2013 Jul;44(7):1859-65. doi: 10.1161/STROKEAHA.113.001461. Epub 2013 Jun 4.

5.

Association of carotid artery parameters of atherosclerosis in coronary artery disease.

Kim HS, Cho KI.

J Cardiovasc Ultrasound. 2013 Jun;21(2):72-80. doi: 10.4250/jcu.2013.21.2.72. Epub 2013 Jun 26.

6.

The relationship of carotid three-dimensional ultrasound vessel wall volume with age and sex: comparison to carotid intima-media thickness.

Buchanan DN, Lindenmaier T, McKay S, Bureau Y, Hackam DG, Fenster A, Parraga G.

Ultrasound Med Biol. 2012 Jul;38(7):1145-53. doi: 10.1016/j.ultrasmedbio.2012.02.013. Epub 2012 May 12.

PMID:
22579542
7.

A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes.

Pollex RL, Spence JD, House AA, Fenster A, Hanley AJ, Zinman B, Harris SB, Hegele RA.

Cardiovasc Ultrasound. 2005 Jun 15;3:15.

8.

Validation of 3D ultrasound vessel wall volume: an imaging phenotype of carotid atherosclerosis.

Egger M, Spence JD, Fenster A, Parraga G.

Ultrasound Med Biol. 2007 Jun;33(6):905-14. Epub 2007 Apr 18.

PMID:
17445962
9.

Carotid ultrasound phenotypes in vulnerable populations.

Riccio SA, House AA, Spence JD, Fenster A, Parraga G.

Cardiovasc Ultrasound. 2006 Nov 13;4:44.

10.

Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids.

Taniguchi A, Nakai Y, Fukushima M, Teramura S, Hayashi R, Hama K, Marumoto K, Watanabe T, Yoshioka I, Sakaguchi K, Kishimoto H, Matsushita K, Okumura T, Tokuyama K, Nagasaka S, Sakai M.

Metabolism. 2002 May;51(5):539-43.

PMID:
11979382
11.

Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis.

Krasinski A, Chiu B, Spence JD, Fenster A, Parraga G.

Ultrasound Med Biol. 2009 Nov;35(11):1763-72. doi: 10.1016/j.ultrasmedbio.2009.05.017. Epub 2009 Aug 3.

PMID:
19647921
12.

Dietary intervention to reverse carotid atherosclerosis.

Shai I, Spence JD, Schwarzfuchs D, Henkin Y, Parraga G, Rudich A, Fenster A, Mallett C, Liel-Cohen N, Tirosh A, Bolotin A, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ; DIRECT Group.

Circulation. 2010 Mar 16;121(10):1200-8. doi: 10.1161/CIRCULATIONAHA.109.879254. Epub 2010 Mar 1.

13.

Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions.

Al-Shali K, House AA, Hanley AJ, Khan HM, Harris SB, Mamakeesick M, Zinman B, Fenster A, Spence JD, Hegele RA.

Atherosclerosis. 2005 Feb;178(2):319-25. Erratum in: Atherosclerosis. 2005 Oct;182(2):379-80.

PMID:
15694940
14.

Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness.

Migrino RQ, Bowers M, Harmann L, Prost R, LaDisa JF Jr.

J Cardiovasc Magn Reson. 2011 Aug 3;13:37. doi: 10.1186/1532-429X-13-37.

15.

Comprehensive cardiac rehabilitation for secondary prevention after transient ischemic attack or mild stroke: I: feasibility and risk factors.

Prior PL, Hachinski V, Unsworth K, Chan R, Mytka S, O'Callaghan C, Suskin N.

Stroke. 2011 Nov;42(11):3207-13. doi: 10.1161/STROKEAHA.111.620187. Epub 2011 Sep 22.

16.

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.

Stumpe KO, Agabiti-Rosei E, Zielinski T, Schremmer D, Scholze J, Laeis P, Schwandt P, Ludwig M; MORE study investigators.

Ther Adv Cardiovasc Dis. 2007 Dec;1(2):97-106. doi: 10.1177/1753944707085982.

PMID:
19124398
17.

Childhood obesity-related cardiovascular risk factors and carotid intima-media thickness.

Simşek E, Balta H, Balta Z, Dallar Y.

Turk J Pediatr. 2010 Nov-Dec;52(6):602-11.

18.

Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study.

Herder M, Johnsen SH, Arntzen KA, Mathiesen EB.

Stroke. 2012 Jul;43(7):1818-23. doi: 10.1161/STROKEAHA.111.646596. Epub 2012 May 1.

19.

Pulmonary abnormalities and carotid atherosclerosis in ex-smokers without airflow limitation.

Pike D, Kirby M, Lindenmaier TJ, Sheikh K, Neron CE, Hackam DG, Spence JD, Fenster A, Paterson NA, Sin DD, Coxson HO, McCormack DG, Parraga G.

COPD. 2015 Feb;12(1):62-70. doi: 10.3109/15412555.2014.908833. Epub 2014 Jun 12.

PMID:
24921977
20.

Possible risk factors of carotid artery atherosclerosis in the Japanese population: a primary prevention study in non-diabetic subjects.

Okada M, Miida T, Hama H, Yata S, Sunaga T, Tsuda A, Saito H.

Intern Med. 2000 May;39(5):362-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk